Novo Nordisk develops new mechanical insulin pill with star researchers from MIT

Novo Nordisk has developed a new pill technology, the future basis for an insulin pill, in collaboration with star researcher Robert Langer and his team at MIT. The company expects clinical studies to take place in two to three years.

The new pill technology Lumi consists of a three-pointed needle construction, that is shot into the small intestine by a spring and injects insuline into the intestine wall. Photo: MIT/ PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles